Accession Number:

ADA525186

Title:

Evaluation of RSDL, M291 SDK, 0.5% Bleach, 1% Soapy Water and SERPACWA. Part 1: Challenge with VX

Descriptive Note:

Technical rept. 3 Nov 2004-4 Dec 2007

Corporate Author:

ARMY MEDICAL RESEARCH INST OF CHEMICAL DEFENSE ABERDEEN PROVING GROUND MD

Report Date:

2009-06-01

Pagination or Media Count:

84.0

Abstract:

There is a need for Joint forces to effectively operate across the continuum of global contingency operations. The requirement exists for a pre-exposure barrier skin cream to increase the efficacy of the protective suit and for the ability to decontaminate the skin, individual equipment, and casualties, including those with wounds that have been exposed to chemical, biological, radiological, and nuclear CBRN warfare agents. Current doctrine describes the use of Skin Exposure Reduction Paste Against Chemical Warfare Agents SERPACWA as a barrier skin cream and the M291 Skin Decontamination Kit SDK, 0.5 hypochlorite solution household bleach diluted 1 to 10 and 1 soapy water solution to decontaminate intact skin exposed to chemical warfare agents. Reactive Skin Decontamination Lotion RSDL is a new product approved by the FDA and selected in March 2007 by the Joint Program Executive Office for Chemical and Biological Defense to eventually replace the M291 SDK. This report, the first in a series, directly compares the efficacy of SERPACWA and the four listed decontamination products in the haired guinea pig model following exposure to VX.

Subject Categories:

  • Toxicology
  • Chemical, Biological and Radiological Warfare
  • Protective Equipment

Distribution Statement:

APPROVED FOR PUBLIC RELEASE